ARTICLE | Distillery Therapeutics
Boosting Tnip3-mediated inhibition of MAP3K7 for non-alcoholic steatohepatitis
May 26, 2020 7:04 PM UTC
INDICATION: Non-alcoholic steatohepatitis (NASH)...
BCIQ Company Profiles
BCIQ Target Profiles
INDICATION: Non-alcoholic steatohepatitis (NASH)...
BCIQ Company Profiles
BCIQ Target Profiles